Molecule Details
| InChIKey | VAIOZOCLKVMIMN-PRJWTAEASA-N |
|---|---|
| Compound Name | Eplivanserin |
| Canonical SMILES | CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.92 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12177 |
|---|---|
| Drug Name | Eplivanserin |
| CAS Number | 130579-75-8 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Eplivanserin has been used in trials studying the treatment of Sleep, Insomnia, Chronic Pain, Fibromyalgia, and Primary Insomnia, among others. |
Categories: Antidepressive Agents Benzene Derivatives Cardiovascular Agents Central Nervous System Depressants Fibrin Modulating Agents Hematologic Agents Hydrocarbons, Fluorinated Hydrocarbons, Halogenated Neurotransmitter Agents Serotonin Agents Serotonin Receptor Antagonists
Cross-references: CHEMBL257704 ChemSpider: 13267837 PubChem:5486684 PubChem:347828464 Wikipedia: Eplivanserin ZINC: ZINC000001886642